803 Immune-related adverse events correlate with improved outcomes in patients with advanced non-small cell lung cancer treated with combinations of immune-checkpoint inhibitors and chemotherapy

• Sean Dougherty,
• Lindsey Shantzer,
• Wendy Novicoff,
• John Melson,
• Daniel Reed,
• Alia Lynch,
• Ryan Gentzler

Affiliations

Sean Dougherty

analyst

Lindsey Shantzer

1University of Virginia Health System, Charlottesville, VA, United States

Wendy Novicoff

1University of Virginia Health System, Charlottesville, VA, United States

John Melson

2Tufts Medical Center, Boston, MA, United States

Daniel Reed

3Wake Forest Baptist Health, Winston-Salem, NC, United States

Alia Lynch

1University of Virginia Health System, Charlottesville, VA, United States

Ryan Gentzler

1University of Virginia Health System, Charlottesville, VA, United States